These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9137489)

  • 21. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical assessment of free serum prostate specific antigen (PSA)].
    Chautard D; Daver A; Bali B; Dardari J; Debras B; Colls P; Soret JY
    Prog Urol; 1996 Jun; 6(3):368-74. PubMed ID: 8763691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume.
    Stamey TA; Yemoto CE
    J Urol; 2000 Jan; 163(1):119-26. PubMed ID: 10604328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
    Irani J; Salomon L; Soulié M; Zlotta A; de la Taille A; Doré B; Millet C
    Urology; 2005 Mar; 65(3):533-7. PubMed ID: 15780371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
    Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
    J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.
    Froehner M; Hakenberg OW; Koch R; Schmidt U; Meye A; Wirth MP
    Urol Int; 2006; 76(1):27-30. PubMed ID: 16401917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.
    Obralic N; Kulovac B
    Bosn J Basic Med Sci; 2011 Nov; 11(4):223-7. PubMed ID: 22117828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple prostatic biopsies in the "gray zone" of the specific prostatic antigen].
    Drudi FM; Ricci P; Iannicelli E; Di Nardo R; Novelli L; Laghi A; Perugia G; Passariello R
    Radiol Med; 2000; 99(1-2):81-5. PubMed ID: 10803192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic efficacy of free SPA/total PSA ratio in the diagnosis of prostatic carcinoma].
    Minardi D; Recchioni A; Baldassari M; Governatori D; Giammarco L; De Sio G; Muzzonigro G; Polito M
    Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():93-5. PubMed ID: 9181932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation of prostate biopsy results and ratio of free to total PSA in patients with a total PSA between 4-20 ng/mL.
    Yeniyol CO; Bozkaya G; Cavuşoğlu A; Arslan M; Karaca B; Ayder AR
    Int Urol Nephrol; 2001; 33(3):503-6. PubMed ID: 12230281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response of prostate specific antigen to testosterone surge after luteinizing hormone-releasing hormone analogue in prostate cancer and benign prostatic hyperplasia.
    Agarwal DK; Costello AJ; Peters J; Sikaris K; Crowe H
    BJU Int; 2000 Apr; 85(6):690-5. PubMed ID: 10759667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of free prostate-specific antigen in the diagnosis of prostate cancer.
    Akdas A; Cevik I; Tarcan T; Turkeri L; Dalaman G; Emerk K
    Br J Urol; 1997 Jun; 79(6):920-3. PubMed ID: 9202560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
    Castaldo G; Cecere G; di Fusco V; Prezioso D; d'Armiento M; Salvatore F
    Clin Chim Acta; 1997 Sep; 265(1):65-76. PubMed ID: 9352130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical usefulness of the free and total prostate specific antigen ratio in the diagnosis of cancer of the prostate].
    Morote J; Encabo G; Andreu J; de Torres I
    Med Clin (Barc); 1996 Dec; 107(20):795-6. PubMed ID: 9019610
    [No Abstract]   [Full Text] [Related]  

  • 39. [Validity of digital rectal examination in the era of prostate specific antigen].
    Alonso-Sandoica E; Jara-Rascón J; Martínez-Salamanca JI; Hernández-Fernández C
    Aten Primaria; 2006 Jan; 37(1):9-14. PubMed ID: 16545295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.
    Semjonow A; Hamm M; Rathert P; Hertle L
    Br J Urol; 1994 May; 73(5):538-43. PubMed ID: 7516808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.